| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2013↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $3.9B | $3.8B | $3.9B | $3.7B | $0.9B | $0.8B | $2.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $2.4B | $2.3B | $2.2B | $2.3B | $2.2B | $0.6B | $0.5B | $0.4B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.0B | $0.9B | $0.9B | $0.9B | $0.9B | $0.8B | $0.8B | $0.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.9B | $0.9B | $0.8B | $0.9B | $0.8B | $0.2B | $0.2B | $0.1B |
| EPS (Basic) | $42.17 | $40.67 | $36.10 | $38.79 | $33.25 | $9.15 | $7.95 | $3.72 |
| EPS (Diluted) | $42.05 | $40.48 | $35.90 | $38.41 | $32.78 | $9.03 | $7.84 | $3.63 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2013↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.7B | $3.2B | $3.4B | $3.5B | $3.3B | $2.8B | $2.8B | $2.2B |
| Current Assets | $1.4B | $1.2B | $1.2B | $1.4B | $1.3B | $1.1B | $1.1B | $0.9B |
| Cash & Equivalents | — | — | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Total Liabilities | $3.7B | $3.4B | $3.5B | $3.5B | $3.2B | $2.5B | $2.4B | $1.2B |
| Current Liabilities | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $0.8B | $0.8B | $0.6B |
| Stockholders' Equity | $-0.0B | $-0.1B | $-0.1B | $0.0B | $0.2B | $0.3B | $0.4B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2013↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $1.0B | $1.0B | $0.9B | $0.9B | $0.7B | $0.6B | $0.3B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.3B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.8B | $-0.9B | $-0.9B | $-0.7B | $-0.6B | $-0.7B | $-0.5B | $-0.3B |